2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
262
Thoracic
1
Gastrointestinal
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
6857
Lung Neoplasms
5091
Small Cell Lung Carcinoma
1162
Breast Neoplasms
854
Neoplasms
762
Colorectal Neoplasms
664
Melanoma
566
Ovarian Neoplasms
505
Neoplasm Metastasis
480
Pancreatic Neoplasms
472
Stomach Neoplasms
396
Adenocarcinoma of Lung
396
Prostatic Neoplasms
369
Head and Neck Neoplasms
366
Carcinoma, Renal Cell
349
Esophageal Neoplasms
336
Mesothelioma, Malignant
324
Squamous Cell Carcinoma of Head and Neck
323
Colonic Neoplasms
293
Mesothelioma
289
Urinary Bladder Neoplasms
262
Brain Neoplasms
253
Uterine Cervical Neoplasms
241
Triple Negative Breast Neoplasms
220
Sarcoma
197
Endometrial Neoplasms
195
Carcinoma, Hepatocellular
185
NSCLC
165
Kidney Neoplasms
160
Pleural Effusion, Malignant
159
Interventions
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Thoracic
×
Clear all
NCT06448364
2024-11-06
LTbR
Pfizer
Phase 1
Terminated
4 enrolled